With healthcare organizations expanding across the value chain and blurring boundaries across sectors, Jen, Mindy, and Ryan discuss the trend towards business model and partnership innovation. The episode opens with a discussion of what is driving this change (00:45), specifically consumers, complexity, connected care, cost, the need to create and capturing value, and of course, COVID-19 (04:08). At (06:28) the conversation shifts to discussing a few specific business model and partnership innovation examples, including the Oak Street-One Medical partnership (06:50), the Humana-Dispatch health partnership (08:44), and the Hims/Hers-Privia Health partnership (10:32). Traditional life science companies continue to pursue unique launch partnerships, licensing opportunities, and distribution agreements (11:06), while healthcare organizations are spinning out their in-house technology solutions as independent offerings (12:37). The episode concludes with a discussion of what healthcare leaders should be considering to make these new partnerships and models successful (13:48), including clearly defined goals and success metrics, transparency, and agility.
MedTech Goes Digital
Trending News EU – 11 May 2023
Trending News US – May 4, 2023
DEI & You – Overcoming Data Biases to Advance Health Equity
Trending News US – April 20, 2023
Trending News EU – 13 April 2023
Life Sciences, Health Systems, and Healthcare Tech: Working Together to Deliver Better Patient Outcomes
What if there was a digital tool that could close the loop between patient and provider, using data to improve diagnosis and treatment? Read how Vynamic addressed that question for a Life Sciences client by providing the leadership to make this concept a reality.
- Life Sciences
- Healthcare Technology
Establishing an Agile Commercial Innovation Hub for a Big Pharma That Wants to Operate More Like Healthcare Tech
A global Life Sciences company wanted to reinvent its commercial business model and disrupt the overall healthcare industry by operating more like a nimble biotech. To do so, the company engaged with Vynamic to develop an innovation capability that would allow it to run agile experiments and quickly learn from both the successes and failures while identifying potential solutions. Read how Vynamic established the value proposition, framework, and team structure to enable this innovative capability, while also providing the overall program monitoring and control.
- Life Sciences
- Operating Model & Org Design©
Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy Biotech
A pre-commercial Cell and Gene Therapy client was preparing for the launch of its first product. Read how the newly formed Market Access team contacted Vynamic to assist with strategic planning and process development to support an innovative, outcomes-driven approach for value based contracting arrangements.
- Life Sciences
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.